<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>61(9)</volume><submitter>Sloan M</submitter><funding>LUPUS UK</funding><pubmed_abstract>&lt;h4>Objective&lt;/h4>To better understand rheumatology patient and clinician pandemic-related experiences, medical relationships and behaviours in order to help identify the persisting impacts of the COVID-19 pandemic and inform efforts to ameliorate the negative impacts and build upon the positive ones.&lt;h4>Methods&lt;/h4>Rheumatology patients and clinicians completed surveys (patients n = 1543, clinicians n = 111) and interviews (patients n = 41, clinicians n = 32) between April 2021 and August 2021. A cohort (n = 139) of systemic autoimmune rheumatic disease patients was also followed up from March 2020 to April 2021. Analyses used sequential mixed methods. Pre-specified outcome measures included the Warwick-Edinburgh Mental wellbeing score (WEMWBS), satisfaction with care and healthcare behav</pubmed_abstract><journal>Rheumatology (Oxford, England)</journal><pagination>3723-3736</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8755362</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Will 'the feeling of abandonment' remain? Persisting impacts of the COVID-19 pandemic on rheumatology patients and clinicians.</pubmed_title><pmcid>PMC8755362</pmcid><pubmed_authors>Harwood R</pubmed_authors><pubmed_authors>Barrere C</pubmed_authors><pubmed_authors>Bosley M</pubmed_authors><pubmed_authors>Sutton S</pubmed_authors><pubmed_authors>Gordon C</pubmed_authors><pubmed_authors>Modi R</pubmed_authors><pubmed_authors>Sloan M</pubmed_authors><pubmed_authors>Blane M</pubmed_authors><pubmed_authors>Brimicombe J</pubmed_authors><pubmed_authors>Holloway L</pubmed_authors><pubmed_authors>Lever E</pubmed_authors><pubmed_authors>D'Cruz D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Will 'the feeling of abandonment' remain? Persisting impacts of the COVID-19 pandemic on rheumatology patients and clinicians.</name><description>&lt;h4>Objective&lt;/h4>To better understand rheumatology patient and clinician pandemic-related experiences, medical relationships and behaviours in order to help identify the persisting impacts of the COVID-19 pandemic and inform efforts to ameliorate the negative impacts and build upon the positive ones.&lt;h4>Methods&lt;/h4>Rheumatology patients and clinicians completed surveys (patients n = 1543, clinicians n = 111) and interviews (patients n = 41, clinicians n = 32) between April 2021 and August 2021. A cohort (n = 139) of systemic autoimmune rheumatic disease patients was also followed up from March 2020 to April 2021. Analyses used sequential mixed methods. Pre-specified outcome measures included the Warwick-Edinburgh Mental wellbeing score (WEMWBS), satisfaction with care and healthcare behav</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2026-06-12T04:05:07.096Z</modification><creation>2022-02-11T15:15:25.601Z</creation></dates><accession>S-EPMC8755362</accession><cross_references><pubmed>34995345</pubmed><doi>10.1093/rheumatology/keab937</doi></cross_references></HashMap>